SG Americas Securities
TNGX icon

SG Americas Securities’s Tango Therapeutics TNGX Stock Holding History

SG Americas Securities’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$507K Buy
24,257
+2,251
+10% +$31.3K ﹤0.01% 2178
2025
Q4 		$195K Buy
+22,006
New +$190K ﹤0.01% 2939
2025
Q2 		– Sell
-17,029
Closed -$23K – 3589
2025
Q1 		$23K Sell
17,029
-4,934
-22% -$12.1K ﹤0.01% 3367
2024
Q4 		$68K Buy
21,963
+2,319
+12% +$10.8K ﹤0.01% 2847
2024
Q3 		$151K Buy
+19,644
New +$187K ﹤0.01% 2731
2024
Q2 		– Sell
-30,429
Closed -$242K – 3307
2024
Q1 		$242K Buy
30,429
+4,203
+16% +$45.1K ﹤0.01% 1846
2023
Q4 		$260K Buy
26,226
+5,573
+27% +$48.4K ﹤0.01% 1940
2023
Q3 		$233K Buy
+20,653
New +$126K ﹤0.01% 2223
2023
Q2 		– Sell
-22,444
Closed -$89K – 3152
2023
Q1 		$89K Buy
22,444
+3,978
+22% +$23.1K ﹤0.01% 2950
2022
Q4 		$134K Sell
18,466
-4,278
-19% -$30.1K ﹤0.01% 2513
2022
Q3 		$82K Buy
22,744
+5,633
+33% +$24.1K ﹤0.01% 2904
2022
Q2 		$78K Buy
+17,111
New +$104K ﹤0.01% 3194

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

SG Americas Securities's TNGX Position: Q1 2026 in Review

SG Americas Securities increased its Tango Therapeutics (TNGX) stake by 10% in Q1 2026, buying an estimated $31.3K and bringing the position to 24,257 shares worth $507K. The position accounts for ﹤0.01% of the portfolio, ranked #2178.

SG Americas Securities first reported a position in TNGX in Q2 2022 and has held it in 12 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • SG Americas Securities held 24,257 shares of Tango Therapeutics worth $507K as of Q1 2026.
  • SG Americas Securities bought 2,251 Tango Therapeutics shares in Q1 2026, an estimated $31.3K.
  • Tango Therapeutics made up ﹤0.01% of SG Americas Securities's portfolio in Q1 2026, its #2178 holding.
  • SG Americas Securities first reported a position in Tango Therapeutics in Q2 2022 and has held it in 12 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.